Incyte
INCY
#1143
Rank
NZ$36.35 B
Marketcap
NZ$182.00
Share price
5.54%
Change (1 day)
62.23%
Change (1 year)

Incyte (INCY) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$9.87 Billion

According to Incyte's latest financial reports the company has NZ$9.87 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Incyte - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$8.92 B45.96%
2024-12-31$NZ$6.11 B-25.51%
2023-12-31$NZ$8.20 B19.23%
2022-12-31$NZ$6.88 B24.71%
2021-12-31$NZ$5.51 B52.51%
2020-12-31$NZ$3.61 B-6.2%
2019-12-31$NZ$3.85 B34.37%
2018-12-31$NZ$2.87 B25.05%
2017-12-31$NZ$2.29 B279.15%
2016-12-31$NZ$0.60 B142.15%
2015-12-31$NZ$0.25 B-340.04%
2014-12-31$-NZ$0.11 Billion-55.67%
2013-12-31$-NZ$0.24 Billion10.49%
2012-12-31$-NZ$0.22 Billion-26.9%
2011-12-31$-NZ$0.3 Billion153.22%
2010-12-31$-NZ$0.12 Billion-18.49%
2009-12-31$-NZ$0.15 Billion-62.94%
2008-12-31$-NZ$0.39 Billion82.66%
2007-12-31$-NZ$0.21 Billion72.79%
2006-12-31$-NZ$0.13 Billion324.69%
2005-12-31$-NZ$28.38 Million-125.79%
2004-12-31$NZ$0.11 B-53.65%
2003-12-31$NZ$0.23 B-58.91%
2002-12-31$NZ$0.57 B-45.49%
2001-12-31$NZ$1.06 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
NZ$68.34 B 592.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$158.72 B 1,507.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.77 B 454.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.13 B 63.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$1.75 B-82.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.39 B-95.98%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$44.51 Million-100.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
NZ$50.64 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.26 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA